Trachoma Treatment Market Trends

• The high prevalence of trachoma serves as a significant growth driver for the market. Trachoma is a leading cause of preventable blindness globally, particularly in low-resource settings with poor sanitation and limited access to healthcare.
  
• For instance, as per the Pan American Health Organization (PAHO), globally, in April 2023, an estimated 115.7 million people lived in areas where the prevalence of trachoma in children aged 1 to 9 years was ≥5%. Further, the estimated global burden of trachomatous trichiasis in 2023 was 1.5 million cases.
  
• This high prevalence has led to increased efforts by governments, non-profit organizations, and pharmaceutical companies to develop and distribute treatments, driving the growth of the market.
  
• Thus, as awareness of the disease grows and initiatives to eliminate trachoma gains momentum, the market is expected to expand further, addressing the significant unmet medical need in affected communities.